MediWound (MDWD) Competitors

$16.98
-0.31 (-1.79%)
(As of 05/17/2024 ET)

MDWD vs. FTLF, CDXC, NAII, MTEX, ACB, BTMD, MNMD, CLLS, VCXB, and CVRX

Should you be buying MediWound stock or one of its competitors? The main competitors of MediWound include FitLife Brands (FTLF), ChromaDex (CDXC), Natural Alternatives International (NAII), Mannatech (MTEX), Aurora Cannabis (ACB), biote (BTMD), Mind Medicine (MindMed) (MNMD), Cellectis (CLLS), 10X Capital Venture Acquisition Corp. III (VCXB), and CVRx (CVRX). These companies are all part of the "medical" sector.

MediWound vs.

FitLife Brands (NASDAQ:FTLF) and MediWound (NASDAQ:MDWD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, risk, institutional ownership, profitability, valuation and community ranking.

FitLife Brands has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Comparatively, MediWound has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500.

MediWound received 388 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 62.18% of users gave MediWound an outperform vote while only 0.00% of users gave FitLife Brands an outperform vote.

CompanyUnderperformOutperform
FitLife BrandsOutperform Votes
No Votes
Underperform Votes
2
100.00%
MediWoundOutperform Votes
388
62.18%
Underperform Votes
236
37.82%

2.3% of FitLife Brands shares are owned by institutional investors. Comparatively, 46.8% of MediWound shares are owned by institutional investors. 61.2% of FitLife Brands shares are owned by company insiders. Comparatively, 9.2% of MediWound shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

FitLife Brands has a net margin of 12.48% compared to FitLife Brands' net margin of -35.94%. MediWound's return on equity of 28.66% beat FitLife Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
FitLife Brands12.48% 28.66% 15.09%
MediWound -35.94%-20.22%-10.08%

MediWound has a consensus price target of $32.00, suggesting a potential upside of 88.46%. Given FitLife Brands' higher probable upside, analysts plainly believe MediWound is more favorable than FitLife Brands.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FitLife Brands
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
MediWound
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, FitLife Brands had 5 more articles in the media than MediWound. MarketBeat recorded 6 mentions for FitLife Brands and 1 mentions for MediWound. FitLife Brands' average media sentiment score of 1.19 beat MediWound's score of 0.67 indicating that MediWound is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
FitLife Brands
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MediWound
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

FitLife Brands has higher revenue and earnings than MediWound. MediWound is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FitLife Brands$52.70M2.42$5.30M$1.4818.75
MediWound$18.69M8.63-$6.72M-$0.77-22.05

Summary

FitLife Brands beats MediWound on 9 of the 17 factors compared between the two stocks.

Get MediWound News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDWD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDWD vs. The Competition

MetricMediWoundMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$161.17M$1.30B$5.30B$7.96B
Dividend YieldN/A2.52%43.94%3.91%
P/E Ratio-22.059.02154.7018.77
Price / Sales8.6310.722,362.9377.92
Price / CashN/A197.3236.6031.98
Price / Book4.952.025.754.76
Net Income-$6.72M-$165.47M$106.86M$217.17M
7 Day Performance-1.96%-0.66%1.41%2.90%
1 Month Performance7.67%0.64%4.29%6.57%
1 Year Performance73.62%5.00%7.61%10.17%

MediWound Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FTLF
FitLife Brands
0 of 5 stars
$29.62
-2.8%
N/A+63.2%$136.24M$52.70M27.4237Earnings Report
CDXC
ChromaDex
3.5905 of 5 stars
$3.66
+8.3%
$6.00
+63.9%
+111.5%$276.48M$83.57M-73.20106Short Interest ↑
NAII
Natural Alternatives International
0 of 5 stars
$6.50
-0.9%
N/A-15.6%$39.59M$154.01M-9.29317Analyst Forecast
MTEX
Mannatech
0.2613 of 5 stars
$7.40
+0.5%
N/A-36.9%$13.91M$131.96M-6.17213Analyst Forecast
News Coverage
ACB
Aurora Cannabis
0.7393 of 5 stars
$7.00
+4.8%
N/A+17.1%$381.82M$211.59M-2.411,130Options Volume
News Coverage
BTMD
biote
2.2199 of 5 stars
$5.95
-1.0%
$8.11
+36.3%
+1.8%$443.45M$185.36M54.09194Short Interest ↑
News Coverage
MNMD
Mind Medicine (MindMed)
2.8575 of 5 stars
$8.49
+0.5%
$17.67
+108.1%
+161.0%$596.59MN/A-2.8957
CLLS
Cellectis
2.3429 of 5 stars
$3.04
+2.4%
$8.50
+179.6%
+69.0%$168.96M$9.19M-1.77231Gap Down
VCXB
10X Capital Venture Acquisition Corp. III
0 of 5 stars
$10.96
flat
N/A+5.5%$166.70MN/A0.00N/ANews Coverage
CVRX
CVRx
2.7101 of 5 stars
$7.72
+0.4%
$16.60
+115.0%
-34.3%$166.68M$39.29M-3.13200Short Interest ↑

Related Companies and Tools

This page (NASDAQ:MDWD) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners